Clinical Trials - June 4, 2019
Rapid progress of Sigrid Therapeutics trial
The company has completed treatment of 25% of patients in the STAR trial of its medical device, SiPore15, and is well on track to finalize results by Q4 of this year. The company also reports that treatment compliance is good and the safety profile continues to look positive. STAR trial STAR aims to demonstrate that […]
Drug development - May 31, 2019
Stem cells in drug development
The high cost and uncertain outcomes of developing new drugs has taken a toll on research over the past several years. Few companies can take the hit of investing hundreds of thousands of dollars in research and testing, only to see dangerous side effects emerge during the final stages, human clinical trials. The pursuit of […]
Biotech Business - January 3, 2018
Biosimilars may cut health spending by $54 billion over next decade shows new report
According to a new analysis from RAND Corp, introducing biosimilar versions of complex biologic drugs could cut healthcare spending in the US by $54 billion over the next decade. The savings estimate is about 20 percent larger than a similar analysis done by RAND researchers three years ago, representing both improved analysis methods and rapid […]
Biotech Business - December 14, 2017
New results from Immuneed
Biotech company Immuneed has published two scientific publications, supporting both its immuno-service and its immuno-oncology offerings. The articles demonstrate Immuneed’s whole blood loop assay, a tool to predict first-infusion reactions of immunotherapeutics1, and a novel targeting and adjuvant strategy to improve T cell responses that can be used for cancer vaccines. “When performing preclinical safety […]
Drug development - December 14, 2017
Oncoinvent opens new facilities
Yesterday, Oncoinvent held an opening ceremony for its new production and lab facilities. The new production facility contains a Grade B clean room, two Category B type isotope production suites, a quality control laboratory, and packaging area that will support qualified operations for manufacturing, analytical control, packaging and labelling of Radspherin for upcoming preclinical and […]
Biotech Business - June 29, 2017
Cytovation announces private fundraising round of NOK 20m
The financing was led by a group of private investors in Norway and the company will use these funds to advance lead product CyPep-1 into a Phase I clinical trial. Cytovation is developing CyPep-1, a peptide consisting of 27 amino acids that selectively targets cutaneous warts through the destruction of the cell membrane and creating […]
